Has anyone compared the quality of images?
Monday January 31, 11:50 am Eastern Time
Company Press Release
SOURCE: GE Medical Systems
GE Senographe 2000D Digital Mammography System Receives FDA Approval
WAUKESHA, Wis., Jan. 31 /PRNewswire/ -- GE Medical Systems announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to begin U.S. sales of the GE Senographe 2000D, the world's first fully digital mammography system.
The GE Senographe 2000D is designed to generate digital mammographic images that can be used for screening and diagnosis of breast cancer. The GE Senographe 2000D is intended to be used in the same clinical applications as traditional film-based mammographic systems.
Breast cancer is the second most common cancer among women in the United States, and nearly 180,000 American women are diagnosed with breast cancer each year.
``This is the single biggest advance in mammography in 30 years, and women throughout the United States now have access to a powerful new tool in the fight against breast cancer,' said Jeff Immelt, President and CEO of GE Medical. ``The FDA is to be commended for approving this technology, which will serve as the foundation for many remarkable future advances in breast care.'
The GE Senographe 2000D is based on proprietary technology developed by GE to produce digital x-ray images without film. GE Medical has spent 13 years and more than $100 million developing this technology, and has been granted more than 100 U.S. patents.
In 1999, the GE Senographe 2000D was approved for sale in Europe, Canada, Latin America, and much of Asia, and nearly 50 systems are already in use in those areas.
As part of the development of the GE Senographe 2000D, feasibility systems were installed at the following investigational sites: University of Massachusetts, University of Colorado, Massachusetts General Hospital, Northwestern University Medical School, Hospital of the University of Pennsylvania, University of Chicago, University of South Florida, and Bethesda Medical Center.
In addition to today's news about the FDA approval of the GE Senographe 2000D, GE Medical announced that it will conduct a media conference in New York on Wednesday, February 23 to discuss the details of this new technology and its impact on women worldwide. Scheduled speakers include company executives and leading medical experts who have used the Senographe 2000D.
About GE Medical Systems
GE Medical Systems is a $6 billion global leader in medical information and technology. Its offerings include networking and productivity tools, health care information systems, patient monitoring devices, conventional and digital X-ray, computed tomography (CT), magnetic resonance (MR), ultrasound, positron emission tomography, and nuclear medicine.
SOURCE: GE Medical Systems
-------------------------------------------------------------------------------- |
